GSK Announces Shareholders Meeting to Discuss Novartis Deal
GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.
Grifols Announces FDA Approval of Plasma Fractionation Unit
Spanish-based healthcare company, Grifols, announced that FDA approved the expansion of the plasma fractionation unit at its Clayton, North Carolina facility.
GE Partners with Takeda to Develop Therapeutic Drugs for Liver Disease
GE Healthcare and Takeda Pharmaceutical Company announced an alliance to develop therapeutic drugs in the field of hepatic fibrosis to treat various liver diseases.
Perrigo Agrees to Acquire Omega Pharma for $4.5 Billion
The deal between the two companies will strengthen Perrigo's presence in Europe.
Novo Nordisk Builds New Labs in Denmark, Adds to US Staff
Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark.
AbbVie/Shire Deal Officially Off
AbbVie to pay Shire $1.635 billion break fee for terminating purchase agreement.
Lilly to Close Manufacturing Facility in Puerto Rico
Lilly announces the closure of its Guayama, Puerto Rico manufacturing facility amid continued investments at other plants.
AbbVie Reconsiders Shire Offer
AbbVie sends Shire notice that it is reconsidering its offer recommendation.
Vetter Announces Personnel Changes in its Development Service Division
Vetter's clinical manufacturing services continue to attract new business.
Marrying Big Data with Personalized Medicine
Data analytic strategies can help companies capitalize on personalized medicine.
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
GSK Fined in China Bribery Scandal
GSK is found guilty of offering bribes to doctors and is fined $489 million.
No Signs of a Slowdown in Mergers
A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.
AbbVie to Acquire Shire for $54.7 Billion
After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.
Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal
Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.
Sandoz Commits to New UN Program to Combat Child Mortality
Sandoz will supply antibiotic to developing countries as part of the United Nations' Every Newborn Action Plan.
GSK Offers $1 Million Award for Healthcare Innovations
GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world&s poorest children.
Pharma Capacity to Produce Cytotoxic Injectable Drugs Constricts
PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.
Changing Market Dynamics Require New Approaches to Innovation
Pharma companies are looking to external sources for innovations that meet future needs.
Novartis Hosts 13th Annual Malaria Expert Panel
Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.
More than 430 New Medicines in Development for Chronic Diseases
PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.
Bureaucratic Roadblocks Threaten Biopharma Growth
Protecting intellectual property rights is vital to biopharmaceutical innovation.
Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys
ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.
Pfizer and Avon Announce Metastatic Breast Cancer Program
Pfizer and the Avon Foundation for Women Breast Cancer Grants Program will award up to $1 million in grants to advocacy, academic, and other not-for-profit organizations.
GSK Announces Vaccine Price Freeze in Support of GAVI Alliance
GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.
Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust
Kymab receives $40 million investment for clinical development of antibody therapeutics.
AstraZeneca Rejects Pfizer's Final Offer
AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.
Tigermed Acquires Frontage Laboratories
Tigermed acquires Frontage Laboratories for $50.25 million.
National Institutes of Health Sets New Goals for Global Health Research and Training
The Fogarty International Center, a component of the US NIH, calls for a focus on noncommunicable diseases and implementing science in low-resource settings.
Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association
Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.
